M. Juebner

Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P‐Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What?

U. Fuhr, M. Kinzig, F. Sörgel, 2018, Clinical pharmacology and therapeutics.

Quantification of direct-acting oral anticoagulants: Application of a clinically validated liquid chromatography tandem-mass spectrometry method to forensic cases.

M. Wiesen, C. Müller, T. Streichert, 2020, Drug testing and analysis.

In vitro phase I metabolism of the synthetic cannabimimetic JWH-018

M. Thevis, M. Rothschild, M. Juebner, 2010, Analytical and bioanalytical chemistry.

Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.

M. Thevis, W. Schänzer, M. Juebner, 2011, Drug testing and analysis.

Inhibition of 1,4-butanediol metabolism in human liver in vitro

M. Rothschild, M. Juebner, Daniel Lenz, 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

Not only smoking is deadly: fatal ingestion of e-juice—a case report

M. Rothschild, K. Mercer-Chalmers-Bender, M. Juebner, 2015, International Journal of Legal Medicine.

Assessing Cognitive and Psychomotor Performance in Patients with Fibromyalgia Syndrome

R. Sabatowski, F. Petzke, H. Gerbershagen, 2014, Pain and Therapy.

The novel β‐defensin DEFB123 prevents lipopolysaccharide‐mediated effects in vitro and in vivo

Erik Maronde, W. Forssmann, A. Schulz, 2006 .

The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo.

Erik Maronde, W. Forssmann, A. Schulz, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Insights into Mechanisms and Proteomic Characterisation of Pseudomonas aeruginosa Adaptation to a Novel Antimicrobial Substance

S. Müller, P. Cierniak, M. Juebner, 2013, PloS one.